Immediate Impact
7 by Nobel laureates 26 from Science/Nature 82 standout
Citing Papers
Towards targeting the breast cancer immune microenvironment
2024 Standout
Therapeutic targeting of tumour myeloid cells
2023 Standout
Works of Brenda O’Connell being referenced
Abstract P5-16-02: Updated efficacy, safety and translational data from MARIO-3, a phase II open-label study evaluating a novel triplet combination of eganelisib (IPI-549), atezolizumab (atezo), and nab-paclitaxel (nab-pac) as first-line (1L) therapy for locally advanced or metastatic triple-negative breast cancer (TNBC)
2022
Initial results from first-in-human study of IPI-549, a tumor macrophage-targeting agent, combined with nivolumab in advanced solid tumors.
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Brenda O’Connell | 1355 | 472 | 76 | 291 | 20 | 1.6k | |
| Norbert Schuster | 1143 | 418 | 113 | 253 | 18 | 1.6k | |
| Lizhao Wu | 1350 | 815 | 84 | 314 | 22 | 1.8k | |
| Jan van Riggelen | 1300 | 474 | 75 | 327 | 20 | 1.7k | |
| Lauren D. Wood | 1244 | 578 | 89 | 334 | 20 | 1.7k | |
| Michael Wanzel | 1202 | 570 | 71 | 244 | 25 | 1.6k | |
| Steffi Herold | 1353 | 480 | 41 | 265 | 22 | 1.6k | |
| Duanduan Ma | 1060 | 451 | 86 | 206 | 28 | 1.6k | |
| Brendan D’Souza | 953 | 389 | 75 | 152 | 23 | 1.5k | |
| Paulien Cornelissen‐Steijger | 1117 | 552 | 126 | 285 | 23 | 1.5k | |
| José Grenet | 1445 | 661 | 103 | 389 | 26 | 1.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...